Mo, Great article, thank you! When the FDA approved the expanded use of Brilacidin for compassionate use against CV, The FDA had information concerning the patient reactions to Brilacidin in the ongoing trial, (not the data) the FDA also has the data from the Hospitals who have adminstered Brilacidin under the compassionate use authorization. I wouldn't want to jump to far ahead, but I would suggest, the FDA approval is pointing to very successful trial, that we will see when we get the top line results. Exciting times for IPIX shaerholders, soon, we are only 2 days out from when the count down begins in earnest.